These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2958968)

  • 1. Effect of sodium phosphonoformate on blood group antibody detection.
    Douglas R
    Vox Sang; 1987; 53(1):61. PubMed ID: 2958968
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sodium phosphonoformate on blood group antibody detection.
    Hunt AF; Jones MT; Howkins GJ
    Vox Sang; 1986; 51(3):231-2. PubMed ID: 2949433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
    Muratore O; Varnier OE; Raffanti SP; Schito GC
    Eur J Clin Microbiol; 1984 Oct; 3(5):447-9. PubMed ID: 6238823
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.
    Schwers A; Pastoret PP; Vindevogel H; Leroy P; Aguilar-Setien A; Godart M
    J Comp Pathol; 1980 Oct; 90(4):625-33. PubMed ID: 6268670
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition of human herpesvirus-6 by phosphonoformate.
    Streicher HZ; Hung CL; Ablashi DV; Hellman K; Saxinger C; Fullen J; Salahuddin SZ
    J Virol Methods; 1988 Sep; 21(1-4):301-4. PubMed ID: 2972736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.
    Hartshorn KL; Sandstrom EG; Neumeyer D; Paradis TJ; Chou TC; Schooley RT; Hirsch MS
    Antimicrob Agents Chemother; 1986 Jul; 30(1):189-91. PubMed ID: 3019235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vesicular stomatitis virus transcriptase in vitro by phosphonoformate and ara-ATP.
    Chanda PK; Banerjee AK
    Virology; 1980 Dec; 107(2):562-6. PubMed ID: 6161479
    [No Abstract]   [Full Text] [Related]  

  • 16. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
    Nordenfelt E; Werner B
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS.
    Beldekas JC; Levy EM; Black P; Von Krogh G; Sandstrom E
    Lancet; 1985 Nov; 2(8464):1128-9. PubMed ID: 2865599
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
    Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
    Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.